According to the Jimin Health announcement, Zhang Xueqin, the controlling shareholder of the company, Shuangge Group, signed a share transfer agreement with Jin Keqi Innovation to transfer a total of 26.26 million unrestricted tradable shares to Jinkeqi Innovation through an agreed transfer method, accounting for 5.00% of the company's total share capital. The transfer price is 6.08 yuan/share, and the total transfer consideration is 160 million yuan. Before this change in equity, the information disclosure obligors held a total of 41.54% of the shares; after the change, they held a total of 36.54% of the shares, and the controlling shareholder and actual controller of the company will not change. The share transfer still requires compliance confirmation from the Shanghai Stock Exchange and the completion of share transfer registration.

According to the Jimin Health announcement, Zhang Xueqin, the controlling shareholder of the company, Shuangge Group, signed a share transfer agreement with Jin Keqi Innovation to transfer a total of 26.26 million unrestricted tradable shares to Jinkeqi Innovation through an agreed transfer method, accounting for 5.00% of the company's total share capital. The transfer price is 6.08 yuan/share, and the total transfer consideration is 160 million yuan. Before this change in equity, the information disclosure obligors held a total of 41.54% of the shares; after the change, they held a total of 36.54% of the shares, and the controlling shareholder and actual controller of the company will not change. The share transfer still requires compliance confirmation from the Shanghai Stock Exchange and the completion of share transfer registration.